{"slug":"selank-adderall-jitteriness","verification":{"valid":true,"entries":22,"head":"3d99d5899f0066e6a8af395243c1a5c3f0f8aa0837f374c12c58275864e1c84e"},"energy":{"passes":22,"tokens_in":15981,"tokens_out":2339,"tokens_total":18320,"cost_usd":0,"models":{"grok/grok-4.3":2,"grok-4.3":6,"system/audit-repair":8,"kimi/moonshot-v1-8k":2,"gemini/gemini-2.5-flash":1,"repair":1,"fill-slots":1,"owner":1},"head":"3d99d5899f0066e6a8af395243c1a5c3f0f8aa0837f374c12c58275864e1c84e"},"provenance":[{"ts":"2026-06-29T09:18:08.239Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"PEPTIDE DEFINITIONS (use for mechanism accuracy; no medical claims):\nBPC-157 — Body Protection Compound. Derived from gastric juice protein. Builds new blood vessels into damaged tissue locally. 100+ animal/cell studies (tendon, gut, muscle, bone, nerve).\nTB-500 — Synthetic Thymosin Beta-4. Moves repair cells to damage; clears stuck inflammation systemically. Production drops ~60% by age 60.\nARA-290 — Nerve repair peptide with human clinical trial data. Regrows damaged nerves; does not mask nerve pain.\nSemax — Brain peptide; upregulates BDNF for neuroprotection and cognitive recovery.\nSelank — Anxiolytic peptide; reduces anxiety without sedation or addiction (non-benzodiazepine pathway).\nPT-141 — Sexual function; brain-level arousal signaling (FDA-approved mechanism as Vyleesi).\nDSIP — Delta Sleep Inducing Peptide; natural deep sleep without Ambien-class hangover.\nKPV — Gut-specific anti-inflammatory; calms gut lining without systemic immune suppression.\nGHK-Cu — Tissue remodeling; builds collagen scaffolding. Production drops 60-80% with age.\nThymosin Alpha-1 — Immune modulation; supports immune function without suppressing it.\n\nWrite a data-first, evidence-graded article: Selank for Adderall-Induced Jitteriness and Anxiety\n\nAudience: 3-5M on Adderall + Xanax. The problem: Adderall causes anxiety treated with addictive benzos. Why Selank maps: anxiolytic without sedation or addiction risk; different pathway than benzos. Novelty: 10/10.\n\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate rat studies from human trials from user reports. No medical claims or treatment promises. Use repair-vs-suppression framing where relevant. register: source_ledger.","response":"{\n  \"slug\": \"selank-for-adderall-induced-jitteriness-and-anxiety\",\n  \"title\": \"Selank for Adderall-Induced Jitteriness and Anxiety\",\n  \"body\": \"## Selank Overview\\n\\nSelank is a synthetic heptapeptide derived from tuftsin with reported anxiolytic properties in limited clinical contexts.\\n\\n## Evidence on Anxiolytic Effects\\n\\n### Human Data\\n\\nA 2008 Russian study of 62 patients with generalized anxiety disorder (GAD) and neurasthenia compared Selank to medazepam. Anxiolytic effects were similar between groups; Selank additionally showed antiasthenic and psychostimulant effects (human tier). [Zozulia et al., 2008](https://pubmed.ncbi.nlm.nih.gov/18454096/)\\n\\nAdditional small Russian trials (sample sizes ~30–70) reported anxiolytic effects comparable to benzodiazepines without sedation, cognitive impairment, or dependence; one 2015 study examined combination with benzodiazepines (human tier). No large-scale Western RCTs exist; most data are from Russian-language journals with small samples and limited long-term follow-up (human tier).\\n\\n### Preclinical Data\\n\\nRat studies show Selank reduces anxiety-like behaviors in stress models and may enhance diazepam effects under chronic mild stress conditions without equivalent sedation (preclinical tier).\\n\\n### Mechanism\\n\\nSelank modulates GABA_A receptor subunit gene expression and influences enkephalin levels; effects appear indirect and non-allosteric in the manner of benzodiazepines (mechanistic tier).\\n\\n## Relevance to Stimulant-Related Jitteriness\\n\\nNo human trials examine Selank specifically for Adderall-induced anxiety or jitteriness (no human data). Mapping relies on general anxiolytic observations and non-sedating profile (speculative tier).\\n\\n## User Reports\\n\\nAnecdotal reports on forums describe reduced anxiety and improved calm during stimulant use or standalone, with subjective descriptions of “feeling like myself” without sedation (anecdotal tier).\\n\\n## Comparison to Benzodiazepines\\n\\nBenzodiazepines ","tokens_in":0,"tokens_out":0,"cost":0,"prev":"genesis","hash":"69e71f52100f9b0395318fac581e23623b2d06973c76e8393c052a4c4417e1ca"},{"ts":"2026-06-29T11:13:08.383Z","model":"grok-4.3","action":"sources","prompt":"","input":"selank-adderall-jitteriness","response":"8 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"69e71f52100f9b0395318fac581e23623b2d06973c76e8393c052a4c4417e1ca","hash":"e69edbc7e65103f29ea193ddd3ce10b1576f3ae6c1f546c846f074d989e781c1"},{"ts":"2026-06-29T11:13:36.776Z","model":"grok-4.3","action":"sources","prompt":"","input":"selank-adderall-jitteriness","response":"5 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"e69edbc7e65103f29ea193ddd3ce10b1576f3ae6c1f546c846f074d989e781c1","hash":"7689b59001e6b004223d8438355d90fd8187763b3eecd1d4ad3e0571ec8bf31f"},{"ts":"2026-06-29T11:14:10.248Z","model":"grok-4.3","action":"sources","prompt":"","input":"selank-adderall-jitteriness","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"7689b59001e6b004223d8438355d90fd8187763b3eecd1d4ad3e0571ec8bf31f","hash":"bdb679a3354a560757f5ec4bf4960317c8ca083590fae097883365273066200d"},{"ts":"2026-06-29T11:15:12.445Z","model":"grok-4.3","action":"sources","prompt":"","input":"selank-adderall-jitteriness","response":"5 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"bdb679a3354a560757f5ec4bf4960317c8ca083590fae097883365273066200d","hash":"fee738c2b2ae2b466cfb14ef0050bf799079f9c8a8068c01514b86bc301f7742"},{"ts":"2026-06-29T11:15:31.114Z","model":"grok-4.3","action":"sources","prompt":"","input":"selank-adderall-jitteriness","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"fee738c2b2ae2b466cfb14ef0050bf799079f9c8a8068c01514b86bc301f7742","hash":"19dd3c519156e502936ed1223d0c258b8ffb5cfc2adaac4980ec8f9c314b613c"},{"ts":"2026-06-29T12:49:11.875Z","model":"system/audit-repair","action":"repair","prompt":"","input":"selank-adderall-jitteriness","response":"{\"materialized\":0,\"before\":[\"missing constitution slots: what_it_is, what_is_known, what_is_unknown, limitations, disclaimer\"],\"after\":[\"missing constitution slots: what_it_is, what_is_known, what_is_unknown, disclaimer\"]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"19dd3c519156e502936ed1223d0c258b8ffb5cfc2adaac4980ec8f9c314b613c","hash":"5d882abb02932ad6b328671bf2b282f5a9b8932f0d274bdd7f99fa4fcf385121"},{"ts":"2026-06-29T12:49:12.510Z","model":"system/audit-repair","action":"claim","prompt":"","input":"selank-adderall-jitteriness c31","response":"Selank for Adderall-Induced Jitteriness and Anxiety is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"5d882abb02932ad6b328671bf2b282f5a9b8932f0d274bdd7f99fa4fcf385121","hash":"8f8561de73fdbb524f8c9713dec58b6699ec5ebb541638b4631ee322975113c1"},{"ts":"2026-06-29T12:49:12.613Z","model":"system/audit-repair","action":"claim","prompt":"","input":"selank-adderall-jitteriness c32","response":"Per this ledger on Selank for Adderall-Induced Jitteriness and Anxiety: 15 scientific and 12 anecdotal sources are catalogued; 7 preclinical claim(s) summarize animal/cell literature in-catalogue.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"8f8561de73fdbb524f8c9713dec58b6699ec5ebb541638b4631ee322975113c1","hash":"cb3f2008e2696ec717626b109d890d0f637b712833125d70550c67011e482774"},{"ts":"2026-06-29T12:49:12.731Z","model":"system/audit-repair","action":"claim","prompt":"","input":"selank-adderall-jitteriness c33","response":"Not established in this ledger: large randomized human trials for common marketed uses; long-term human safety beyond small pilots; condition-specific efficacy where only anecdotal or preclinical sources exist (explicit gaps remain in question graph).","tokens_in":0,"tokens_out":0,"cost":0,"prev":"cb3f2008e2696ec717626b109d890d0f637b712833125d70550c67011e482774","hash":"19c76fca4b5b4a9e602f372e30a839b979b172a41bd1600c521217d4eba258da"},{"ts":"2026-06-29T12:49:12.858Z","model":"system/audit-repair","action":"claim","prompt":"","input":"selank-adderall-jitteriness c34","response":"Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"19c76fca4b5b4a9e602f372e30a839b979b172a41bd1600c521217d4eba258da","hash":"dfa5b85ae7ba14ccb9d7d69571627d3a884011d0fdf005b0ca82859fd995b375"},{"ts":"2026-06-29T12:49:13.501Z","model":"system/audit-repair","action":"repair","prompt":"","input":"selank-adderall-jitteriness","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"dfa5b85ae7ba14ccb9d7d69571627d3a884011d0fdf005b0ca82859fd995b375","hash":"d1f6e7e7f8500e90e750b5d1c0716303392fc4219c213c4ec15b01fa4fe9877d"},{"ts":"2026-06-29T13:11:19.231Z","model":"kimi/moonshot-v1-8k","action":"collaborate","prompt":"","input":"selank-adderall-jitteriness","response":"I am adding explicit gaps in knowledge and naming anecdotal claimants as instructed. I am not Grok because I am providing additional context and claims that are not present in the existing topology, which is my role as collaborator #1 on the miscsubjects peptide evidence ledger.","tokens_in":2774,"tokens_out":527,"cost":0,"prev":"d1f6e7e7f8500e90e750b5d1c0716303392fc4219c213c4ec15b01fa4fe9877d","hash":"863a514058c1c9ba9b796527a429b7703edf39f26afc862fd0e6d0fc3a7e8c7d"},{"ts":"2026-06-29T13:12:10.621Z","model":"kimi/moonshot-v1-8k","action":"collaborate","prompt":"","input":"selank-adderall-jitteriness","response":"I am adding explicit gaps in knowledge and naming sources for anecdotal claims as instructed, which are missing from the current ledger. I am not Grok because I am focusing on filling in the gaps and sourcing anecdotes, rather than challenging existing claims.","tokens_in":2776,"tokens_out":299,"cost":0,"prev":"863a514058c1c9ba9b796527a429b7703edf39f26afc862fd0e6d0fc3a7e8c7d","hash":"9d6f7d27b22b0ce8f20e91a98b1f4dc7ce65347e76b8a650d429436c4deee579"},{"ts":"2026-06-29T13:21:25.528Z","model":"system/audit-repair","action":"repair","prompt":"","input":"selank-adderall-jitteriness","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"9d6f7d27b22b0ce8f20e91a98b1f4dc7ce65347e76b8a650d429436c4deee579","hash":"58534d3bf24c280bce41f8080973aff3a00a2a822cb1f51746b6d3d4c11b7890"},{"ts":"2026-06-29T13:21:26.770Z","model":"system/audit-repair","action":"repair","prompt":"","input":"selank-adderall-jitteriness","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"58534d3bf24c280bce41f8080973aff3a00a2a822cb1f51746b6d3d4c11b7890","hash":"babb568a5d029818ba78eb38400a838c7b6d7d1225fa69ede883f4c6479ab943"},{"ts":"2026-06-29T14:38:57.729Z","model":"gemini/gemini-2.5-flash","action":"collaborate","prompt":"","input":"selank-adderall-jitteriness","response":"I am Gemini, not Grok. I have added three claims to the ledger, focusing on the 'who_claims_what' slot to materialize orphan sources from the topology and provide a more complete picture of discussions and professional perspectives surrounding Selank. I also challenged a broad, unsourced anecdotal claim with more specific, sourced anecdotal evidence to improve the ledger's precision.","tokens_in":2911,"tokens_out":577,"cost":0,"prev":"babb568a5d029818ba78eb38400a838c7b6d7d1225fa69ede883f4c6479ab943","hash":"7ecf680cf401b234b979534e90fd71afc29788d40213c641b38e83641b169fbf"},{"ts":"2026-06-29T14:39:50.469Z","model":"grok/grok-4.3","action":"synthesize_body","prompt":"","input":"selank-adderall-jitteriness","response":"## Regeneration vs degeneration — where this fits\nAnxiety and jitteriness after stimulant use can reflect ongoing tissue stress in the nervous system. The body runs breakdown and repair at the same time. When breakdown from repeated stimulant load exceeds repair, the anxiety signal stays active. Selank research asks whether stabilizing neurochemistry supports recovery rather than only muting the signal.\n\n## What it is\nSelank is a peptide studied for anxiety-related pathways. Russian clinical work tested it for generalized anxiety disorder and neurasthenia. It is not a benzodiazepine.\n\n## How it works\nSelank affects GABA_A receptor subunit expression through indirect routes. This differs from benzodiazepines that bind directly to the receptor. Animal work also links it to cytokine regulation and possible effects on memory under stress.\n\n## Why it would work (logic chain)\nIf anxiety follows stimulant-induced stress, then a compound that modulates GABA tone without broad sedation could lower the anxiety signal. If the same compound shows anti-asthenic effects in trials, then it might support clearer function while reducing jitter. If anecdotal reports note calm focus, then the pathway may match the reported outcome. Each step rests on the prior one.\n\n## Why people take it\nPeople take it when they want anxiety support without sedation or dependence risk. Some combine it with stimulants to reduce edge or jitter. Some use it alone for baseline anxiety.\n\n## How many people take it\nExact numbers are unknown. The ledger contains 9 Reddit posts and 3 other anecdote sources that mention use with stimulants.\n\n## Evidence inventory\n- Human sources: 2 (one 2008 trial n=62, one 2008 immunomodulation study).\n- Animal sources: 9 (rat stress models, ethanol memory model).\n- Anecdote sources: 18 (9 Reddit, 3 other).\nTotal sources catalogued: 15 studies plus 12 anecdote entries.\n\n## What scientists say\nThe 2008 trial (source s1) gave Selank or medazepam to 62 patients with GAD or neura","tokens_in":7520,"tokens_out":936,"cost":0,"prev":"7ecf680cf401b234b979534e90fd71afc29788d40213c641b38e83641b169fbf","hash":"d82f4d0dbed116be497d284b6a50628c03eda3ebdb02f86ac1e478300b174b6e"},{"ts":"2026-06-29T18:30:24.303Z","model":"grok-4.3","action":"sources","prompt":"","input":"selank-adderall-jitteriness","response":"5 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"d82f4d0dbed116be497d284b6a50628c03eda3ebdb02f86ac1e478300b174b6e","hash":"0c946a980cb51a09a7b516c398469fc6fc0930f09bcb29452687a270a531ef68"},{"ts":"2026-06-29T20:01:02.765Z","model":"repair","action":"repair","prompt":"","input":"selank-adderall-jitteriness","response":"{\"materialized\":0,\"before\":[],\"after\":[],\"focus_stats\":{\"roles_assigned\":0,\"excluded_sources\":0,\"commercial_sources\":0,\"cut_claims\":0,\"core\":15,\"cycle\":0,\"adjacent\":0}}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"0c946a980cb51a09a7b516c398469fc6fc0930f09bcb29452687a270a531ef68","hash":"a9b271867ecb60f9a72374391a6c0589a65fd088cf7abb95466d9cac17cc691a"},{"ts":"2026-06-29T21:12:01.443Z","model":"fill-slots","action":"claim","prompt":"","input":"selank-adderall-jitteriness c49","response":"Selank for Adderall-Induced Jitteriness and Anxiety is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"a9b271867ecb60f9a72374391a6c0589a65fd088cf7abb95466d9cac17cc691a","hash":"31ada4b6cf5351401caa2c4f429b75fba155515b46f92aed2ed377f8693f5f8f"},{"ts":"2026-07-17T02:41:34.625Z","model":"owner","action":"voxel_divide","prompt":"","input":"selank-adderall-jitteriness","response":"29 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"31ada4b6cf5351401caa2c4f429b75fba155515b46f92aed2ed377f8693f5f8f","hash":"3d99d5899f0066e6a8af395243c1a5c3f0f8aa0837f374c12c58275864e1c84e"}]}